Tyra Bioscience (TYRA) Stock Forecast & Price Target

Compare

120 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

TYRA Analyst Ratings

Strong Buy

10 Buy

0 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Tyra

Bioscience

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

TYRA Stock 12 Month Forecast

Average Price Target

$48.71

▲(34.48% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Tyra Bioscience in the last 3 months. The average price target is $48.71 with a high forecast of $59.00 and a low forecast of $37.00. The average price target represents a 34.48% change from the last price of $36.22.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"$7","60":"$60","20.25":"$20.3","33.5":"$33.5","46.75":"$46.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":59,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$59.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":48.71,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$48.71</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":37,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$37.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,20.25,33.5,46.75,60],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.52,34.55692307692308,36.59384615384616,38.63076923076923,40.667692307692306,42.70461538461539,44.74153846153846,46.77846153846154,48.815384615384616,50.85230769230769,52.88923076923077,54.926153846153845,56.963076923076926,{"y":59,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.52,33.76538461538462,35.010769230769235,36.25615384615385,37.501538461538466,38.74692307692308,39.9923076923077,41.23769230769231,42.48307692307692,43.728461538461545,44.973846153846154,46.21923076923077,47.464615384615385,{"y":48.71,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.52,32.86461538461539,33.20923076923077,33.55384615384616,33.89846153846154,34.24307692307693,34.58769230769231,34.932307692307695,35.276923076923076,35.621538461538464,35.966153846153844,36.31076923076923,36.65538461538462,{"y":37,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":14.46,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.71,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.72,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.48,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.6,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.72,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.37,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.53,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.84,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.81,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.29,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.02,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.52,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$59.00

Average Price Target$48.71

Lowest Price Target$37.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Tyler Van Buren

TD Cowen

―

Buy

―

Reiterated

03/10/26

Analysts Are Bullish on These Healthcare Stocks: Tyra Bioscience (TYRA), Veeva Systems (VEEV)

Li Watsek

Cantor Fitzgerald

―

Buy

―

Reiterated

03/04/26

Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC) and Tyra Bioscience (NASDAQ: TYRA)

Allison Bratzel

Piper Sandler

$42

Buy

15.96%

Upside

Reiterated

03/03/26

Tyra Bioscience (TYRA) Gets a Buy from Piper Sandler

Sami Corwin

William Blair

―

Buy

―

Reiterated

03/03/26

Analysts' Top Healthcare Picks: Stryker (SYK), Tyra Bioscience (TYRA)

Mitchell Kapoor

H.C. Wainwright

$30→$45

Buy

24.24%

Upside

Reiterated

03/03/26

Tyra Biosciences: FGFR3-Focused Pipeline and Upcoming Clinical Catalysts Support Buy Rating and Favorable Risk‑Reward

Matthew Biegler

Oppenheimer

$50

Buy

38.05%

Upside

Reiterated

03/03/26

Tyra Bioscience (TYRA) Receives a Buy from Oppenheimer

Robert Driscoll

Wedbush

$53

Buy

46.33%

Upside

Reiterated

03/03/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Eliana Merle

Barclays

$59

Buy

62.89%

Upside

Reiterated

02/27/26

Barclays Keeps Their Buy Rating on Tyra Bioscience (TYRA)

Christopher Raymond

Raymond James

$55

Buy

51.85%

Upside

Reiterated

02/23/26

Raymond James Reaffirms Their Buy Rating on Tyra Bioscience (TYRA)

Jason Zemansky

Bank of America Securities

$32→$37

Buy

2.15%

Upside

Reiterated

02/18/26

Bank of America Securities Sticks to Its Buy Rating for Tyra Bioscience (TYRA)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Tyler Van Buren

TD Cowen

―

Buy

―

Reiterated

03/10/26

Analysts Are Bullish on These Healthcare Stocks: Tyra Bioscience (TYRA), Veeva Systems (VEEV)

Li Watsek

Cantor Fitzgerald

―

Buy

―

Reiterated

03/04/26

Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC) and Tyra Bioscience (NASDAQ: TYRA)

Allison Bratzel

Piper Sandler

$42

Buy

15.96%

Upside

Reiterated

03/03/26

Tyra Bioscience (TYRA) Gets a Buy from Piper Sandler

Sami Corwin

William Blair

―

Buy

―

Reiterated

03/03/26

Analysts' Top Healthcare Picks: Stryker (SYK), Tyra Bioscience (TYRA)

Mitchell Kapoor

H.C. Wainwright

$30→$45

Buy

24.24%

Upside

Reiterated

03/03/26

Tyra Biosciences: FGFR3-Focused Pipeline and Upcoming Clinical Catalysts Support Buy Rating and Favorable Risk‑Reward

Matthew Biegler

Oppenheimer

$50

Buy

38.05%

Upside

Reiterated

03/03/26

Tyra Bioscience (TYRA) Receives a Buy from Oppenheimer

Robert Driscoll

Wedbush

$53

Buy

46.33%

Upside

Reiterated

03/03/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Eliana Merle

Barclays

$59

Buy

62.89%

Upside

Reiterated

02/27/26

Barclays Keeps Their Buy Rating on Tyra Bioscience (TYRA)

Christopher Raymond

Raymond James

$55

Buy

51.85%

Upside

Reiterated

02/23/26

Raymond James Reaffirms Their Buy Rating on Tyra Bioscience (TYRA)

Jason Zemansky

Bank of America Securities

$32→$37

Buy

2.15%

Upside

Reiterated

02/18/26

Bank of America Securities Sticks to Its Buy Rating for Tyra Bioscience (TYRA)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tyra Bioscience

3 Months

xxx

Success Rate

18/27 ratings generated profit

Average Return

+14.76%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +14.76% per trade.

1 Year

Jason ZemanskyBank of America Securities

Success Rate

8/10 ratings generated profit

Average Return

+108.17%

reiterated a buy rating 26 days ago

Copying Jason Zemansky's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +108.17% per trade.

2 Years

xxx

Success Rate

10/10 ratings generated profit

Average Return

+140.64%

reiterated a xxx

rating 26 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +140.64% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TYRA Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, TYRA has received 22 Buy Ratings, 29 Hold Ratings, and 0 Sell Ratings. TYRA average Analyst price target in the past 3 months is 48.71.

Each month's total comprises the sum of three months' worth of ratings.

TYRA Financial Forecast

TYRA Earnings Forecast

Next quarter’s earnings estimate for TYRA is -$0.58 with a range of -$0.64 to -$0.53. The previous quarter’s EPS was -$0.57. TYRA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year TYRA has Performed in-line its overall industry.

No data currently available

TYRA Sales Forecast

Next quarter’s sales forecast for TYRA is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. TYRA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year TYRA has Performed in-line its overall industry.

TYRA Stock Forecast FAQ

What is TYRA’s average 12-month price target, according to analysts?

Based on analyst ratings, Tyra Bioscience’s 12-month average price target is 48.71.

What is TYRA’s upside potential, based on the analysts’ average price target?

Tyra Bioscience has 34.48% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TYRA a Buy, Sell or Hold?

Tyra Bioscience has a consensus rating of Strong Buy which is based on 10 buy ratings, 0 hold ratings and 0 sell ratings.

What is Tyra Bioscience’s price target?

The average price target for Tyra Bioscience is 48.71. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $59.00 ,the lowest forecast is $37.00. The average price target represents 34.48% Increase from the current price of $36.22.

What do analysts say about Tyra Bioscience?

Tyra Bioscience’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of TYRA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Tyra Bioscience (TYRA) Stock Forecast & Price Target

TYRA Analyst Ratings

TYRA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Tyra Bioscience

TYRA Analyst Recommendation Trends

TYRA Financial Forecast

TYRA Earnings Forecast

TYRA Sales Forecast

TYRA Stock Forecast FAQ

Detailed List of Analyst Forecasts